Hyperthermia plus mitomycin (HYMN)

• Research type

  Research Study

• Full title

  A randomised controlled phase III trial comparing hyperthermia plus mitomycin to a second course of bacillus Calmette-Guerin or standard therapy in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance bacillus Calmette-Guerin therapy.

• IRAS ID

  10306

• Sponsor organisation

  University College London

• Eudract number

  2008-005428-99

• ISRCTN Number

  85785327

• Clinicaltrials.gov Identifier

  N/A

• Research summary

  N/A

• REC name

  London - Brent Research Ethics Committee

• REC reference

  09/H0717/56

• Date of REC Opinion

  19 Oct 2009

• REC opinion

  Further Information Favourable Opinion